Nazli Demirkaya investigates whether HIV-infected patients undergoing long-term combination antiretroviral treatment are still at risk of developing retinal neurodegeneration. Another iam is to detrmine the value of retinal thickness as a potential biomarker for brain alterations in HIV-infected patients.
N. Demirkaya: In Search of Retinal Biomarkers for HIV Related Neurodegeneration: The AGEhIV and NOVICE Studies.
Prof. R.O. Schlingemann
Dr F.W.N.M. Wit
Dr F.D. Verbraak
This event is open to the public.